Wide Ranks

MIST

Milestone Pharmaceuticals Inc.

1.87

Top Statistics
Market Cap 99 M Forward PE -2.31 Revenue Growth 0.00 %
Current Ratio 19.13 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -1.91 Enterprise / Revenue Price To Sales Trailing12 Months Infinity
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 83 M Total Cash Per Share 1.26 Total Debt 53 M
Total Debt To Equity 166.53 Current Ratio 19.13 Book Value Per Share 0.3890
All Measures
Short Ratio 246.00 % Message Board Id finmb_36171059 Shares Short Prior Month 436935
Return On Equity -1.34 City Montreal Uuid fef8fa0a-f2b8-346f-8ec3-172c3e402265
Previous Close 1.85 First Trade Date Epoch Utc 1 B Book Value 0.3890
Beta 1.73 Total Debt 53 M Volume 285803
Price To Book 4.81 Fifty Two Week Low 1.12 Total Cash Per Share 1.26
Shares Short Previous Month Date 1 B Target Median Price 7.00 Max Age 86400
Recommendation Mean 2.00 Sand P52 Week Change 0.3133 Target Mean Price 10.25
Net Income To Common -48409000 Short Percent Of Float 0.0086 Implied Shares Outstanding 53 M
Trailing Peg Ratio None Last Fiscal Year End 1 B Average Daily Volume10 Day 328740
Average Volume10days 328740 Total Cash 83 M Next Fiscal Year End 1 B
Held Percent Insiders 0.0069 Trailing PE 0.0000 Date Short Interest 1 B
Most Recent Quarter 1 B Regular Market Previous Close 1.85 Target Low Price 2.00
Gmt Off Set Milliseconds -18000000 Fifty Day Average 1.60 Open 1.84
Free Cashflow -23841876 State QC Dividend Yield 0.00 %
Return On Assets -0.3309 Time Zone Short Name EST Trailing Eps -0.8000
Day Low 1.84 Address1 1111 Dr. Frederik-Philips Boulevard Shares Outstanding 53 M
Price Hint 4 Target High Price 25.00 Website https://www.milestonepharma.com
52 Week Change -0.4401 Average Volume 275089 Forward Eps -0.8600
Recommendation Key buy Compensation As Of Epoch Date 1 B Quick Ratio 1867.00 %
Is_sp_500 False Regular Market Day High 1.91 Profit Margins 0.00 %
Debt To Equity 166.53 Fifty Two Week High 3.52 Day High 1.91
Shares Short 454790 Regular Market Open 1.84 Industry Key biotechnology
Earnings Growth 0.00 % Revenue Growth 0.00 % Shares Percent Shares Out 0.0085
Operating Cashflow -36943000 Currency USD Time Zone Full Name America/New_York
Market Cap 99 M Is_nasdaq_100 False Zip H4M 2X6
Quote Type EQUITY Industry Biotechnology Long Name Milestone Pharmaceuticals Inc.
Regular Market Day Low 1.84 Held Percent Institutions 0.5701 Current Price 1.87
Address2 Suite 420 Enterprise To Ebitda -1.91 Financial Currency USD
Current Ratio 19.13 Industry Disp Biotechnology Number Of Analyst Opinions 4
Country Canada Float Shares 52 M Two Hundred Day Average 1.56
Enterprise Value 93 M Price To Sales Trailing12 Months Infinity Forward PE -2.31
Regular Market Volume 285803 Ebitda -49194000 Exchange NMS
Go to Yahoo Finance Go to Seeking Alpha 
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines.

The company's lead product candidate is etripamil, a novel and potent calcium channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II clinical trial for the treatment of atrial fibrillation and rapid ventricular rate.

It has a license and collaboration agreement with Ji Xing Pharmaceuticals to develop and commercialize etripamil prophylactic and therapeutic uses in humans, as well as with the Montreal Heart Institute, the WCN network, and other research centers.

The company was incorporated in 2003 and is headquartered in Montréal, Canada.